The purpose of this study is to evaluate the safety and tolerability of C-1101 administered as a single dose, transforaminal epidural injection compared to sterile saline
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence and severity of treatment emergent adverse events (TEAEs)
Timeframe: From Day 1 to Week 24
Incidence and severity of adverse events of special interest (AESIs)
Timeframe: From Day 1 to Week 24
Senior Director, Clinical Development Operations